This webinar will be hosted live and available on-demand

Thursday, October 12, 2023 
2:30-3:30 PM Eastern Time 

Chimeric antigen receptor T (CAR T) cell therapy is a groundbreaking immunotherapy used to treat cancer. After genetic modification and purification of the patient-derived T cells, researchers need to expand the cell population before they administer them back into the patient. This expansion process can take up to 3 weeks, all while the patient is awaiting treatment.   

In this webinar brought to you by Miltenyi Biotec, Chris Ashdown will discuss how low-intensity vibration may be the key to accelerating CAR T production and improving its effectiveness in patients.

Topics to be covered 

  • Introduction to low-intensity vibration
  • The effect of low-intensity vibration on T cells
  • How low-intensity vibration improves CAR T manufacturing and efficacy
Christopher Ashdown

Christopher Ashdown
MD/PhD student
Biomedical Engineering Department
Stony Brook University

Sponsored by